Protein biomarker signature for risk classification of hormone receptor positive breast cancer identified by reverse phase protein array based tumor profiling

被引：0
|
作者：
Sonntag, J. [1 ]
Bender, C. [1 ]
Aulmann, S. [2 ]
Von der Heyde, S. [3 ]
Burwinkel, B. [4 ]
Wiemann, S. [1 ]
Beissbarth, T. [3 ]
Sinn, H. P. [2 ]
Schneeweiss, A. [5 ]
Korf, U. [1 ]
机构：
[1] German Canc Res Ctr, Heidelberg, Germany
[2] Heidelberg Univ, Dept Pathol, Heidelberg, Germany
[3] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany
[4] Heidelberg Univ, Dept Gynecol & Obstet, Heidelberg, Germany
[5] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1010
引用
收藏
页码：S212 / S212
页数：1
相关论文
共 50 条
  • [21] Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays
    Gujral, T. S.
    Karp, R. L.
    Finski, A.
    Chan, M.
    Schwartz, P. E.
    MacBeath, G.
    Sorger, P.
    ONCOGENE, 2013, 32 (29) : 3470 - 3476
  • [22] Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study
    Aleskandarany, Mohammed A.
    Negm, Ola H.
    Green, Andrew R.
    Ahmed, Mohamed A. H.
    Nolan, Christopher C.
    Tighe, Patrick J.
    Ellis, Ian O.
    Rakha, Emad A.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (02) : 339 - 348
  • [23] Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study
    Mohammed A. Aleskandarany
    Ola H. Negm
    Andrew R. Green
    Mohamed A. H. Ahmed
    Christopher C. Nolan
    Patrick J. Tighe
    Ian O. Ellis
    Emad A. Rakha
    Breast Cancer Research and Treatment, 2014, 145 : 339 - 348
  • [24] Utilisation of reverse phase protein array analysis to identify signalling pathways activated in lobular breast cancer
    Teo, K.
    Tenhagen, M.
    Byron, A.
    Derksen, P.
    Brunton, V.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S122 - S122
  • [25] Reverse Phase Protein Array is a Useful High Throughput Technique for Assessment of Multiple Proteins in Breast Cancer
    Jerjees, D. A.
    Negm, O. H.
    Alabdullah, M. L.
    Alkaabi, M.
    Mirza, S.
    Abdulajabbar, R.
    Muftah, A.
    Green, A. R.
    Tighe, P. J.
    Band, V.
    Ellis, I. O.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2015, 237 : S30 - S30
  • [26] Development of distant recurrence risk model based on hormone receptor-positive breast cancer gene expression profiling in the Chinese population
    Wang, Xin
    Ma, Li
    Meng, Xiangzhi
    Liu, Jiaqi
    Chai, Jingchao
    Yang, Jingyi
    Yang, Zhi
    Wu, Qixi
    Liu, Yueping
    Ying, Jianming
    Wang, Xiang
    CANCER RESEARCH, 2020, 80 (04)
  • [27] 4-protein signature predicts outcome to tamoxifen treatment in estrogen receptor positive recurrent breast cancer
    De Marchi, Tommaso
    Liu, NingQing
    Tjoa, Mila
    Stingl, Christoph
    Smid, Marcel
    Look, Maxime P.
    Timmermans, Mieke A.
    Braakman, Rene B. H.
    Opdam, Mark
    Linn, Sabine
    Span, Paul
    Sweep, Fred C. G. J.
    Martens, John W. M.
    Luider, Theo M.
    Foekens, John A.
    Umar, Arzu
    CANCER RESEARCH, 2014, 74 (19)
  • [28] New treatment options for metastatic breast cancer revealed by reverse-phase protein microarray and genomic profiling
    Williams, Casey B.
    De, Pradip
    Dey, Nandini
    Williams, Kirstin A.
    Klein, Jessica
    King, Michelle
    Small, Misty
    Cyr, Brigitte
    Willis, Scooter
    Sun, Yuliang
    Carlson, Jennifer
    Young, Brandon M.
    Krie, Amy
    Leyland-Jones, Brian
    CANCER RESEARCH, 2015, 75
  • [29] Reverse-Phase Protein Array for Proteo-Epigenomic Profiling of Colorectal Cancer Patient-Derived Organoids
    Takeda, Shota
    Shiokawa, Taisuke
    Aoyama, Toru
    Yoshioka, Kenichi
    Okamoto, Koji
    Masuda, Mari
    CANCER SCIENCE, 2024, 115 : 488 - 488
  • [30] MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer
    Boesl, Andreas
    Spitzmueller, Andreas
    Jasarevic, Zerina
    Rauch, Stefanie
    Jaeger, Silke
    Offner, Felix
    PLOS ONE, 2017, 12 (08):
12345